醫(yī)藥分類：
抗生素類抗感染制劑:
麗珠集團(tuán)(20.52,0.00,0.00%)⑤、雙鶴藥業(yè)(28.82,0.00,0.00%)⑤、天方藥業(yè)(7.01,0.22,3.24%)④、華北制藥(9.07,0.03,0.33%)⑤、廣濟(jì)藥業(yè)(19.81,0.17,0.87%)③、恒瑞醫(yī)藥(40.38,-0.53,-1.30%)⑤、魯抗醫(yī)藥(6.79,-0.12,-1.74%)⑤、普洛康裕(7.91,-0.09,-1.12%)⑤、現(xiàn)代制藥(8.95,-0.04,-0.44%)⑤、浙江醫(yī)藥(24.98,0.04,0.16%)⑤、華海藥業(yè)(18.10,0.50,2.84%)⑤、京新藥業(yè)(8.45,-0.30,-3.43%)⑤、海正藥業(yè)(19.32,-0.43,-2.18%)⑤、海翔藥業(yè)⑤、西南藥業(yè)(10.36,-0.13,-1.24%)②、西南合成(7.30,0.02,0.27%)②、豐原藥業(yè)(5.87,-0.07,-1.18%)④、白云山(11.12,0.00,0.00%)A⑤、天茂集團(tuán)(8.50,-0.39,-4.39%)③、華邦制藥(18.08,-0.52,-2.80%)②、聯(lián)環(huán)藥業(yè)(14.12,0.12,0.86%)⑤、康美藥業(yè)(9.80,0.09,0.93%)⑤、*ST潛藥③、ST東盛③、海王生物(6.27,-0.22,-3.39%)⑤、*ST四環(huán)(13.13,-0.69,-4.99%)⑤、*ST金花③、*ST金泰(7.13,-0.38,-5.06%)⑤、*ST長信③、一致藥業(yè)(18.17,-0.03,-0.16%)⑤、浙江震元(7.60,-0.03,-0.39%)⑤、華東醫(yī)藥(15.30,0.59,4.01%)⑤、國藥股份(55.55,-2.64,-4.54%)⑤、上海醫(yī)藥(8.26,-0.06,-0.72%)⑤、沃華醫(yī)藥⑤、*ST中新⑤、健康元⑤、*ST迪康①、天士力(15.78,0.12,0.77%)⑤、康恩貝(10.10,-0.05,-0.49%)⑤、益佰制藥(13.24,0.08,0.61%)③、江中藥業(yè)(13.45,0.29,2.20%)④、上海輔仁⑤
非抗生素類抗感染制劑:
海翔藥業(yè)⑤、西南藥業(yè)②
止血鎮(zhèn)痛：
云南白藥(28.11,-0.17,-0.60%)④、獨(dú)一味②
呼吸系統(tǒng)用制劑：
新華制藥(6.68,-0.01,-0.15%)⑤、現(xiàn)代制藥⑤、海正藥業(yè)⑤、ST東盛③、海王生物⑤、*ST金花③、江蘇吳中(4.56,-0.06,-1.30%)⑤、ST國藥③、一致藥業(yè)⑤、*ST迪康①、上實(shí)醫(yī)藥⑤
醫(yī)療器械:
科華生物(24.91,-0.78,-3.04%)⑤、達(dá)安基金⑤、*ST威達(dá)(7.72,0.00,0.00%)②、威爾科技(14.70,-0.20,-1.34%)⑤、魚躍醫(yī)療⑤、萬東醫(yī)療(11.91,-0.30,-2.46%)⑤、新華醫(yī)療(14.91,-0.27,-1.78%)⑤、上實(shí)醫(yī)藥⑤
疫苗：
聯(lián)環(huán)藥業(yè)⑤、天壇生物(15.55,0.00,0.00%)⑤、中牧股份(17.70,-0.36,-1.99%)⑤、金宇集團(tuán)(12.70,-0.18,-1.40%)⑤、上實(shí)醫(yī)藥⑤
血液制品：
華北制藥⑤、華海藥業(yè)⑤、華蘭生物(43.00,-0.14,-0.32%)④、天壇生物⑤、承志股份④、上實(shí)醫(yī)藥⑤、一致藥業(yè)⑤、紫光古漢(7.49,-0.10,-1.32%)③
藥品經(jīng)銷：
英特集團(tuán)(11.09,-0.56,-4.81%)⑤、ST國藥③、一致藥業(yè)③、桐君閣(8.43,-0.02,-0.24%)②、浙江震元⑤、華東醫(yī)藥⑤、國藥股份⑤、南京醫(yī)藥(9.99,-0.03,-0.30%)⑤、第一醫(yī)藥(8.21,-0.17,-2.03%)⑤、上海醫(yī)藥⑤、廣州藥業(yè)(14.75,0.24,1.65%)⑤、昆明制藥(7.55,0.11,1.48%)④、康緣藥業(yè)(20.70,-0.50,-2.36%)⑤、康恩貝⑤、上實(shí)醫(yī)藥⑤、復(fù)星醫(yī)藥(14.89,0.00,0.00%)⑤
|
